LRRK2 and Parkinson disease: We found that GBA1 mutation carriers with abnormal DATscans already show smaller basal forebrain volumes which was not the case in the LRRK2 mutation carriers, indicating a progressive degeneration of the basal forebrain in GBA1, but not LRRK2 mutation carriers, from asymptomatic to PD stages.